Bayer | BAYN - Cash And Equivalent

Stock Price
39.97
Daily Change
-0.52 -1.27%
Monthly
0.86%
Yearly
100.91%
Q2 Forecast
38.53

Bayer reported EUR5.9B in Cash and Equivalent for its fiscal quarter ending in September of 2025.





Cash And Equivalent Change Date
Air Liquide EUR 3.96B 2.05B Dec/2025
Akzo Nobel EUR 1.55B 47M Jun/2025
Alcon AG USD 1.5B 90M Sep/2025
Amarin USD 122.8M 25.08M Sep/2025
Arkema EUR 1.95B 642M Sep/2025
AstraZeneca USD 8.14B 1.08B Sep/2025
BASF EUR 2.67B 811M Dec/2025
Bayer EUR 5.9B 1.34B Sep/2025
Beiersdorf EUR 1.17B 40M Jun/2025
Corteva USD 4.52B 2.01B Dec/2025
Covestro EUR 604M 115M Sep/2025
Essilor EUR 2.79B 535M Jun/2025
Fresenius EUR 1.23B 1.16B Jun/2025
Fresenius Medical Care EUR 1.58B 326.57M Dec/2025
Genmab DKK 1.72B 46M Dec/2025
Givaudan CHF 603M 3M Jun/2024
GlaxoSmithKline GBP 3.3B 303M Sep/2025
GRIFOLS EUR 558.69M 194.13M Jun/2025
Hikma Pharmaceutical USD 236M 48M Jun/2025
Johnson Matthey GBP 542M 49M Jun/2024
Linde USD 5.06B 547M Dec/2025
Lonza CHF 719M 188M Dec/2025
Merck EUR 2.25B 1.08B Sep/2025
Novartis USD 9.56B 2.9B Sep/2025
Nutrien USD 701M 187M Dec/2025
Philips EUR 1.91B 90M Sep/2025
PPG Industries USD 2.16B 331M Dec/2025
Roche Holding CHF 7.55B 579M Jun/2025
Sanofi EUR 7.66B 1.25B Dec/2025
SAP EUR 8.22B 334M Dec/2025
Solvay EUR 410M 77M Sep/2025
UCB EUR 1.57B 1.14B Dec/2024
Umicore EUR 1.11B 903.9M Jun/2025
Vinci EUR 15.07B 130M Jun/2025